5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia. [electronic resource]
Producer: 20200713Description: 52-53 p. digitalISSN:- 2173-5786
- 5-alpha Reductase Inhibitors -- adverse effects
- Animals
- Antineoplastic Agents, Hormonal -- adverse effects
- Breast Neoplasms, Male -- chemically induced
- Cardiovascular Diseases -- drug therapy
- Clinical Trials as Topic
- Dementia -- chemically induced
- Depression -- chemically induced
- Drug Evaluation, Preclinical
- Dutasteride -- adverse effects
- Finasteride -- adverse effects
- Humans
- Insulin Resistance
- Male
- Meta-Analysis as Topic
- Parkinsonian Disorders -- drug therapy
- Prostatic Hyperplasia -- drug therapy
- Rats
- Sexual Dysfunction, Physiological -- chemically induced
- Urinary Bladder Neoplasms -- prevention & control
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.